Senate Republicans are looking for ways to ensure that two ObamaCare funding bills they’re trying to pass don’t put money toward insurance plans that cover abortions.
“There were some questions that were raised in the pro-life community, and we want to make sure we get those addressed so that all conservatives feel comfortable voting for this transition out of ObamaCare, which is what this is all about,” said Sen. Mike Rounds (R-SD).
. . .
Senate Republicans are punting two ObamaCare bills into next year as lawmakers scramble to avoid a government shutdown. GOP Sens. Susan Collins (Maine) and Lamar Alexander (Tenn.) said they have asked Senate Majority Leader Mitch McConnell (R-Ky.) to not bring the bills up this week.
“Rather than considering a broad year-end funding agreement as we expected, it has become clear that Congress will only be able to pass another short-term extension to prevent a government shutdown and to continue a few essential programs. For this reason, we have asked Senator McConnell not to offer this week our legislation,” they said in a joint statement.
. . .
The individual mandate repeal actually doesn’t take effect until 2019, Laszewski noted, “but I doubt many consumers knew that when they decided not to sign up during all of the news reports about the individual mandate being repealed.”
Thomas Miller, JD, resident fellow at the American Enterprise Institute, a right-leaning think tank here, sees the repeal as “more of a ‘mercy killing’ (putting it out of its chronically ineffective and unpopular misery),” he said in an email. As to whether more people will become uninsured if the mandate is repealed, “Self-serving claims by insurance sector interests and diehard ACA defenders that mandate repeal will trigger widespread disruption and despair in health care markets are vastly exaggerated, as long as other coverage subsidy dollars from taxpayers keep flowing. Good riddance to a half-hearted effort at trying to coerce some mostly less-affluent Americans into buying coverage they did not want, could not afford, or both.”
. . .
Last November, the American people sent a message to Washington: Get things done. With Republican control of both chambers of Congress and the Oval Office, the time to enact pro-growth, pro-innovation policies that benefit American workers and businesses is now.
This month, Congress and the Trump administration have the opportunity to significantly boost one of America’s most vibrant and growing industries by suspending the federal excise tax on medical devices. This misguided tax is set to go back into effect on Jan. 1, which is why Reps. Jackie Walorski, R-Ind., and Erik Paulsen, R-Minn., recently introduced legislation that would suspend the medical device tax for five years.
. . .
Republican lawmakers will overturn a key piece of the Affordable Care Act in their tax overhaul, a victory in a long GOP campaign against the health law.
Senate Majority Leader Mitch McConnell said the compromise tax bill from House and Senate negotiators will end the health law’s requirement that all individuals buy insurance or pay a fine.
The bill will “repeal Obamacare’s individual mandate tax, delivering relief to low- and middle-income Americans who have struggled under an unpopular and unworkable law,” the Kentucky Republican said in an emailed statement.
. . .
ObamaCare’s “Cadillac tax” has emerged as a sticking point in bipartisan negotiations over delaying certain health-care taxes before the end of the year.
Democrats are pushing to delay the “Cadillac tax” on high-cost health plans, which is despised by unions, but Republicans are pushing back and have resisted including the Cadillac tax in the package, sources say.
. . .
With Congress seemingly on the brink of repealing the Affordable Care Act’s centerpiece requirement that most people get insurance or pay a penalty, Democrats are warning such a move would be disastrous, and Republicans are anticipating a sweeping symbolic victory.
Senate Republicans included a measure to repeal the mandate in their recently passed tax overhaul; the House didn’t, leaving GOP leaders to hammer out a final agreement for the compromise bill they hope to pass by year’s end. President Donald Trump on Friday night threw his weight behind the push to strike the mandate, promising a crowd in Pensacola, Fla., that it would soon be gone.
. . .
How many individuals would knowingly want to enroll in a form of health coverage with “persistently inferior” outcomes? A new study published in the Journal of the American Medical Association Oncology suggests that Medicaid provides those persistently inferior outcomes in the nation’s largest state of California, raising more questions about the program that represents the bulk of the coverage expansion under Obamacare. Overall, the study found “substantial and persistent disparities in survival for patients with either no or other public insurance compared with private insurance for all five cancer sites examined.”
. . .
Congressional repeal of Obamacare’s individual insurance mandate penalty is not tantamount to pressing the button on the doomsday machine.
Critics of the Senate tax bill say repeal of the mandate penalty to buy Obamacare coverage will result in a spike in premiums, an increase in the numbers of the uninsured, and a “collapse” of the health insurance markets. In other words, the individual mandate is the “glue” that holds Obamacare together.
The assumption: Millions of Americans will buy Obamacare coverage—regardless of whether they want it or like it—because the government forces them to do it, and penalizes them if they do not.
Do we have compelling evidence that this is, in fact, the case? No.
. . .
At the 2017 Forbes Healthcare Summit, I interviewed Seema Verma, Administrator of the U.S. Centers for Medicare and Medicaid Services, about her policy agenda. CMS is one of the most important agencies in the federal government, administering programs spending over a trillion dollars a year, including Obamacare.
Our discussion was wide-ranging. Verma spoke about fellow Indianan Alex Azar, President Trump’s nominee for the post of Secretary of the Department of Health and Human Services. She discussed her view of what CMS can do on drug pricing. She talked about the opioid crisis, and how to modernize the Medicare and Medicaid programs and empower patients to take charge of their own health care.
. . .